Galena Biopharma To Present At The 25th Annual ROTH Conference

LAKE OSWEGO, Ore., March 11, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will present a corporate update at the 25 th Annual ROTH Conference. The presentation will take place on Monday, March 18, 2013 at 12:00 p.m. PDT.

The presentation will be webcast and available on the Investors section of the Company's website at www.galenabiopharma.com .

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com .

The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647
CONTACT: Madeline Hatton         Toll free: +1 (855) 855-GALE (4253), ext. 109         info@galenabiopharma.com                  or                  Remy Bernarda         IR Sense, LLC         +1 (503) 400-6995         remy@irsense.com

Galena Biopharma, Inc.

If you liked this article you might like

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

How to Dig Deep for Value in These Exuberant Markets

Value Investors Have to Go Deeper

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments